![Jason O’Byrne](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason O’Byrne
Directeur Financier/CFO chez
OLEMA PHARMACEUTICALS, INC.
Fortune : 412 766 $ au 31/08/2026
Profil
Mr. Jason V.
O’Byrne is a Chief Financial & Accounting Officer at Olema Pharmaceuticals, Inc. Mr. O’Byrne was previously employed as a Chief Financial Officer & Executive Vice President by Vir Biotechnology, Inc., a Chief Financial & Accounting Officer by Caribou Biosciences, Inc., a Senior Vice President-Finance by Audentes Therapeutics, Inc., a Regional Controller by General Chemical Corp., and a Regional Head-Commercial Finance APAC by Genentech, Inc. He received his undergraduate degree from the University of British Columbia and an MBA from The Leonard N Stern School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 37 730 ( 0,02% ) | 412 766 $ | 31/08/2026 |
Postes actifs de Jason O’Byrne
| Sociétés | Poste | Début |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Directeur Financier/CFO | 11/08/2026 |
Anciens postes connus de Jason O’Byrne
| Sociétés | Poste | Fin |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Directeur Financier/CFO | 03/08/2026 |
| CARIBOU BIOSCIENCES, INC. | Directeur Financier/CFO | 27/09/2024 |
| AUDENTES THERAPEUTICS, INC. | Directeur Financier/CFO | 01/02/2021 |
General Chemical Corp.
 General Chemical Corp. Industrial SpecialtiesProcess Industries Manufactures and supplies metal lubricant products | Corporate Officer/Principal | 01/01/2005 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Formation de Jason O’Byrne
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
62
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Caribou Biosciences, Inc.
 Caribou Biosciences, Inc. BiotechnologyHealth Technology Develops technology-based solutions for cellular engineering and analysis | Health Technology |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
General Chemical Corp.
General Chemical Corp. Industrial SpecialtiesProcess Industries Manufactures and supplies metal lubricant products | Process Industries |
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes gene therapy products for patients with serious rare diseases | Health Technology |
The Leonard N Stern School of Business
 The Leonard N Stern School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vir Biotechnology, Inc.
 Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
Olema Pharmaceuticals, Inc.
 Olema Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for the treatment & prevention of estrogen receptor positive breast cancer | Health Technology |
